About
RetMap, Inc. develops and designs next-generation electroretinography (ERG) products, including an FDA-cleared disposable contact lens-type ERG electrode, for use in human and veterinary diagnostics of neurodegenerative eye diseases.
Explore RetMap, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.